We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.47%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$56.6B
AUM Growth
+$2.63B
Cap. Flow
-$307M
Cap. Flow %
-0.54%
Top 10 Hldgs %
29.54%
Holding
969
New
110
Increased
283
Reduced
395
Closed
105

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$292M
2
MMM icon
3M
MMM
+$186M
3
BMY icon
Bristol-Myers Squibb
BMY
+$170M
4
WM icon
Waste Management
WM
+$146M
5
DOV icon
Dover
DOV
+$143M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$199M
2
CSX icon
CSX Corp
CSX
+$197M
3
DE icon
Deere & Co
DE
+$122M
4
COP icon
ConocoPhillips
COP
+$110M
5
RBA icon
RB Global
RBA
+$109M

Sector Composition

Rank Sector Weight
1 Technology 28.49%
2 Healthcare 16.13%
3 Financials 10.57%
4 Consumer Discretionary 9.62%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEE icon
776
Ameren
AEE
$30B
$2.32M ﹤0.01%
+26,490
New +$2.12M
IPSC icon
777
Century Therapeutics
IPSC
$343M
$2.26M ﹤0.01%
1,322,751
BALY icon
778
Bally's
BALY
$644M
$2.19M ﹤0.01%
+127,144
New +$2.04M
CPB icon
779
Campbell Soup
CPB
$6.73B
$2.12M ﹤0.01%
+43,346
New +$2.11M
GTM
780
ZoomInfo Technologies
GTM
$1.22B
$2.06M ﹤0.01%
+200,000
New +$2.09M
CRNX icon
781
Crinetics Pharmaceuticals
CRNX
$8.9B
$2.04M ﹤0.01%
40,000
-161,048
-80% -$8.31M
BLD
782
DELISTED
TopBuild
BLD
$2.03M ﹤0.01%
5,000
-70,000
-93% -$28.2M
OPCH icon
783
Option Care Health
OPCH
$3.54B
$1.91M ﹤0.01%
61,000
ALGS icon
784
Aligos Therapeutics
ALGS
$34.1M
$1.89M ﹤0.01%
218,813
+18,813
+9% +$234K
WDAY icon
785
Workday
WDAY
$42B
$1.83M ﹤0.01%
+7,500
New +$1.77M
ATYR
786
aTyr Pharma
ATYR
$49.2M
$1.76M ﹤0.01%
1,000,000
NGNE icon
787
Neurogene
NGNE
$710M
$1.76M ﹤0.01%
41,900
-120,000
-74% -$4.65M
IMA
788
ImageneBio Inc
IMA
$64M
$1.71M ﹤0.01%
82,325
WERN icon
789
Werner Enterprises
WERN
$2.21B
$1.56M ﹤0.01%
40,545
DOCU
790
DocuSign
DOCU
$10.9B
$1.55M ﹤0.01%
+25,000
New +$1.4M
RZLT icon
791
Rezolute
RZLT
$453M
$1.53M ﹤0.01%
315,845
MOG.A icon
792
Moog Inc Class A
MOG.A
$13B
$1.53M ﹤0.01%
7,553
MNDY icon
793
monday.com
MNDY
$3.7B
$1.39M ﹤0.01%
5,000
-25,000
-83% -$6.19M
PSFE icon
794
Paysafe
PSFE
$385M
$1.33M ﹤0.01%
59,394
-256,882
-81% -$5.33M
GH icon
795
Guardant Health
GH
$21.1B
$1.3M ﹤0.01%
56,800
-243,000
-81% -$6.88M
HNRG icon
796
Hallador Energy
HNRG
$698M
$1.23M ﹤0.01%
130,000
SCPH
797
DELISTED
scPharmaceuticals
SCPH
$1.14M ﹤0.01%
+249,260
New +$1.21M
LFST icon
798
Lifestance Health
LFST
$4.07B
$1.12M ﹤0.01%
160,000
-140,000
-47% -$841K
EE icon
799
Excelerate Energy
EE
$1.21B
$1.1M ﹤0.01%
50,000
HCAT icon
800
Health Catalyst
HCAT
$171M
$1.01M ﹤0.01%
124,280
-74,683
-38% -$540K

Similar funds

Adage Capital Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Adage Capital Partners held 969 positions worth $56.6B, up 4.9% from $54B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Adage Capital Partners's Q3 2024 filing shows 110 new, 283 increased, 395 reduced and 105 closed positions. Its largest new stake was EQT Corp: 2,636,935 shares worth $96.6M. The largest sale was Merck, an estimated $199M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2024 buy was EQT Corp: 2,636,935 shares worth $96.6M.
  • Adage Capital Partners added most to Hess in Q3 2024, an estimated $292M increase.
  • Adage Capital Partners's biggest Q3 2024 reduction was Merck, cutting an estimated $199M.
  • Adage Capital Partners fully exited Deere & Co in Q3 2024, selling an estimated $122M.
  • Adage Capital Partners's ten largest holdings make up 30% of its $56.6B portfolio in Q3 2024.
  • Adage Capital Partners opened 110 new positions and closed 105 in Q3 2024.
  • Adage Capital Partners's portfolio value rose 4.9% quarter-over-quarter to $56.6B.

Based on Adage Capital Partners's 13F filing for Q3 2024, filed 14 Nov 2024.